Aspire Biopharma Holdings (ASBP) Inventory (2025 - 2026)

Aspire Biopharma Holdings' (ASBP) quarterly Inventory came in at $369974.0 in Q1 2026, up 46.14% on a QoQ basis from $253160.0 in Q4 2025.

Aspire Biopharma Holdings (ASBP) Inventory (2025 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has 2 years of Inventory data on file, last reported at $369974.0 in Q1 2026.

On a quarterly basis, Inventory changed N/A year-over-year to $369974.0 in Q1 2026; TTM through Mar 2026 was $369974.0, a N/A change from a year earlier, with the FY2025 full-year figure at $253160.0, changed N/A from the prior year.
Inventory for Q1 2026 stood at $369974.0, up from $253160.0 in the prior quarter.
Over the last five years, Inventory for ASBP reached as high as $369974.0 in Q1 2026 and fell as low as $35437.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	681.59 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.77 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.10 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	371.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Aspire Biopharma Holdings	1.21 Mn	-619,284.29	5,750.00	369,974.00

Download Data